A regional-West Midlands audit on implementing the neo-adjuvant chemoimmunotherapy (NACIO) pathway for resectable non-small cell Cancer (NSCLC) patients

被引：0
|
作者：
Chaudhary, Prabhav [1 ]
Budacan, Alina [1 ]
Jegannathen, Apurna [1 ]
Srinivasan, Lakshmi [1 ]
Mahendran, Kajan [1 ]
Ghosh, Ghosh [1 ]
Abah, Udo [1 ]
Sivaramalingam, Muthiah [1 ]
Jesani, Hannah [2 ]
Wotton, Robin [3 ]
机构：
[1] Royal Stoke Univ Hosp, Stoke On Trent, England
[2] Univ Hosp Coventry & Warwickshire, Coventry, England
[3] Queen Elizabeth Hosp Birmingham, Birmingham, England
来源：
LUNG CANCER | 2025年 / 200卷
关键词：
D O I：
10.1016/j.lungcan.2025.108203
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
93
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Pathologic response as a surrogate endpoint for event-free survival in neo-adjuvant immunotherapy trials of resectable non-small cell lung cancer: A subgroup analysis
    Huang, N.
    Shivasabesan, G.
    Lord, S.
    Lee, C. K.
    Kok, P. S.
    ANNALS OF ONCOLOGY, 2024, 35 : S791 - S792
  • [32] Phase II Study of Neo-Adjuvant Chemo/Immunotherapy for Resectable Stages IIIA Non-Small Cell Lung Cancer-Nadim Study-SLCG
    Provencio, M.
    Nadal, E.
    Insa, A.
    Campelo, R. Garcia
    Huidobro, G. G.
    Domine, M.
    Majem, M.
    Rodriguez-Abreu, D.
    Calvo, V.
    Martinez-Marti, A.
    De Castro, J.
    Cobo Dols, M.
    Lopez-Vivanco, G.
    Del Barco, E.
    Bernabe, R.
    Vinolas, N.
    Barneto, I.
    Massuti, B.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S320 - S320
  • [33] Efficacy and Safety of Neoadjuvant Chemoimmunotherapy in Resectable Non-small Cell Lung Cancer (NSCLC): a systematic review and meta-analysis
    Syaj, S.
    Akhdar, M.
    Ababneh, O.
    Hamouri, S.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S235 - S236
  • [34] Neo-Adjuvant Targeted Therapy in Non-Small Cell Lung Cancer Patients: A 10-Year Experience in a Tertiary Medical Center
    Huang, H. C.
    Chiu, C.
    Chiang, C.
    Luo, Y.
    Tsai, C.
    Chen, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S613 - S614
  • [35] Evaluation of acute oesophagitis for neo-adjuvant, hyper-fractional radiochemotherapy of the non-small cell bronchial carcinoma (NSCLC) in the stage III
    Sepe, S.
    Hehr, T.
    Friedel, G.
    Bamberg, M.
    Budach, W.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2008, 184 : 84 - 84
  • [36] Analysis of Prognostic Factors for Surgery after Neo-adjuvant Therapy for Stage III Non-small Cell Lung Cancer
    Zhou, Xuefeng
    Wang, Jianjun
    Wang, Jiashun
    Pan, Yongcheng
    Li, Jingsong
    Wang, Wendong
    Zhao, Feng
    JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES, 2008, 28 (06) : 677 - 680
  • [37] Analysis of prognostic factors for surgery after neo-adjuvant therapy for stage III non-small cell lung cancer
    Xuefeng Zhou
    Jianjun Wang
    Jiashun Wang
    Yongcheng Pan
    Jingsong Li
    Wendong Wang
    Feng Zhao
    Journal of Huazhong University of Science and Technology [Medical Sciences], 2008, 28 : 677 - 680
  • [38] Neoadjuvant Chemoimmunotherapy (CIT) In Resectable Non-Small Cell Lung Cancer (NSCLC): Real-World Treatment Patterns and Surgical Outcomes
    Gibson, A. J.
    Dean, M. L.
    Litt, I.
    Navani, V.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S543 - S543
  • [39] An audit of survival in patients diagnosed with non-small cell lung cancer (NSCLC) and brain metastasis
    Mitchell, T.
    Maclaren, V.
    LUNG CANCER, 2018, 115 : S31 - S31
  • [40] Characterization of the tumor microenvironment by single-cell RNA sequencing in non-small cell lung cancer treated with neo-adjuvant immunotherapy
    Nagl, Laurenz
    Horvath, Lena
    Salcher, Stefan
    Wolf, Dominik
    Pircher, Andreas
    TRANSLATIONAL LUNG CANCER RESEARCH, 2023, 12 (09) : 1959 - 1965
12345